102 related articles for article (PubMed ID: 2448458)
1. Dehydro keto methylene and keto methylene analogues of substance P. Synthesis and biological activity.
Ewenson A; Laufer R; Chorev M; Selinger Z; Gilon C
J Med Chem; 1988 Feb; 31(2):416-21. PubMed ID: 2448458
[TBL] [Abstract][Full Text] [Related]
2. Ketomethylene pseudopeptide analogues of substance P: synthesis and biological activity.
Ewenson A; Laufer R; Chorev M; Selinger Z; Gilon C
J Med Chem; 1986 Feb; 29(2):295-9. PubMed ID: 2419559
[TBL] [Abstract][Full Text] [Related]
3. Pseudopeptide analogues of substance P and leucine enkephalinamide containing the psi (CH2O) modification: synthesis and biological activity.
Roubini E; Laufer R; Gilon C; Selinger Z; Roques BP; Chorev M
J Med Chem; 1991 Aug; 34(8):2430-8. PubMed ID: 1714957
[TBL] [Abstract][Full Text] [Related]
4. [pGlu6,Pro9]SP6-11, a selective agonist for the substance P P-receptor subtype.
Laufer R; Gilon C; Chorev M; Selinger Z
J Med Chem; 1986 Jul; 29(7):1284-8. PubMed ID: 2433445
[TBL] [Abstract][Full Text] [Related]
5. Metabolically stable analogues of substance P: persistent action of partially modified retro-inverso analogues of substance P on rat parotid and hypothalamic slices.
Chorev M; Rubini E; Hart Y; Gilon C; Wormser U; Selinger Z
Eur J Pharmacol; 1986 Aug; 127(3):187-95. PubMed ID: 2428641
[TBL] [Abstract][Full Text] [Related]
6. Proteolytic resistance and biological activity of N-methylated analogs of [pGlu6] substance P6-11.
Wormser U; Laufer R; Chorev M; Gilon C; Selinger Z
Neuropeptides; 1990 May; 16(1):41-9. PubMed ID: 1701226
[TBL] [Abstract][Full Text] [Related]
7. Reduced peptide bond pseudopeptide analogues of substance P. A new class of substance P receptor antagonists with enhanced specificity.
Qian JM; Coy DH; Jiang NY; Gardner JD; Jensen RT
J Biol Chem; 1989 Oct; 264(28):16667-71. PubMed ID: 2476445
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and biological activity of substance P C-terminal hexapeptide and heptapeptide analogues.
Stavropoulos G; Karagiannis K; Cordopatis P; Halle D; Gilon C; Bar-Akiva G; Selinger Z; Chorev M
Int J Pept Protein Res; 1991 Mar; 37(3):180-4. PubMed ID: 1714423
[TBL] [Abstract][Full Text] [Related]
9. Analogues of substance P. Peptides containing D-amino acid residues in various positions of substance P and displaying agonist or receptor selective antagonist effects.
Dutta AS; Gormley JJ; Graham AS; Briggs I; Growcott JW; Jamieson A
J Med Chem; 1986 Jul; 29(7):1163-71. PubMed ID: 2433442
[TBL] [Abstract][Full Text] [Related]
10. Differential activation of the epithelial and smooth muscle NK1 receptors by synthetic tachykinin agonists in guinea-pig trachea.
Figini M; Emanueli C; Bertrand C; Sicuteri R; Regoli D; Geppetti P
Br J Pharmacol; 1997 Jun; 121(4):773-81. PubMed ID: 9208147
[TBL] [Abstract][Full Text] [Related]
11. Antagonists of substance P. Further modifications of substance P antagonists obtained by replacing either positions 7, 9 or 7, 8 and 11 of SP with D-amino acid residues.
Dutta AS; Gormley JJ; Graham AS; Briggs I; Growcott JW; Jamieson A
J Med Chem; 1986 Jul; 29(7):1171-8. PubMed ID: 2433443
[TBL] [Abstract][Full Text] [Related]
12. A peptidases-resistant glycosylated analogue of substance P-(5-11). Specificity towards substance P receptors.
Poujade C; Lavielle S; Torrens Y; Beaujouan JC; Glowinski J; Marquet A
Neuropeptides; 1984 Sep; 4(5):361-8. PubMed ID: 6208505
[TBL] [Abstract][Full Text] [Related]
13. Tachykinin NK-1 receptor probed with constrained analogues of substance P.
Sagan S; Josien H; Karoyan P; Brunissen A; Chassaing G; Lavielle S
Bioorg Med Chem; 1996 Dec; 4(12):2167-78. PubMed ID: 9022979
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and biological activity of analogues of the C-terminal hexapeptide of substance P with modifications at glutaminyl and methioninyl residues. Structure-activity studies.
Antoniou M; Poulos C; Tsegenidis T
Int J Pept Protein Res; 1992 Nov; 40(5):395-400. PubMed ID: 1282903
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of partially modified retro-inverso substance P analogues and their biological activity.
Chorev M; Rubini E; Gilon C; Wormser U; Selinger Z
J Med Chem; 1983 Feb; 26(2):129-35. PubMed ID: 6186812
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and biological activity of substance P C-terminal hexapeptide analogues: structure-activity studies.
Poulos C; Brown JR; Jordan CC
J Med Chem; 1986 Jul; 29(7):1281-4. PubMed ID: 2433444
[TBL] [Abstract][Full Text] [Related]
17. Importance of the leucine side-chain to the spasmogenic activity and binding of substance P analogues.
Lavielle S; Chassaing G; Brunissen A; Rodriguez M; Martinez J; Convert O; Carruette A; Garret C; Petitet F; Saffroy M
Int J Pept Protein Res; 1993 Sep; 42(3):270-7. PubMed ID: 7693605
[TBL] [Abstract][Full Text] [Related]
18. Conformationally restricted cyclic analogues of substance P: insight into the receptor binding process.
Darman PS; Landis GC; Smits JR; Hirning LD; Gulya K; Yamamura HI; Burks TF; Hruby VJ
Biochem Biophys Res Commun; 1985 Mar; 127(2):656-62. PubMed ID: 2579658
[TBL] [Abstract][Full Text] [Related]
19. Tachykinin receptors in smooth muscles: a study with agonists (substance P, neurokinin A) and antagonists.
Mizrahi J; Dion S; D'Orléans-Juste P; Escher E; Drapeau G; Regoli D
Eur J Pharmacol; 1985 Nov; 118(1-2):25-36. PubMed ID: 2417867
[TBL] [Abstract][Full Text] [Related]
20. The role of the N-terminus in the active conformation of the substance P analogues.
Murakoshi T; Yanagisawa M; Kitada C; Fujino M; Otsuka M
Eur J Pharmacol; 1983 May; 90(1):133-7. PubMed ID: 6191999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
